HCP Company Profile (NYSE:HCP)

About HCP (NYSE:HCP)

HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company's segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians' offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.

Industry, Sector and Symbol:

Sector: Finance
Industry: REIT - Healthcare Facilities
Sub-Industry: Specialized REITs
Symbol: NYSE:HCP
CUSIP: 40414L10
Web: www.hcpi.com

Capitalization:

Market Cap: $14.63 billion
Outstanding Shares: 468,572,000

Average Prices:

50 Day Moving Avg: $31.46
200 Day Moving Avg: $30.54
52 Week Range: $27.61 - $40.43

P/E:

Trailing P/E Ratio: 15.06
Foreward P/E Ratio: 36.74
P/E Growth: 9.63

Sales & Book Value:

Annual Revenue: $2.1 billion
Price / Sales: 6.97
Book Value: $12.47 per share
Price / Book: 2.50

Dividend:

Annual Dividend: $1.48
Dividend Yield: 4.7%

Profitability:

EBIDTA: $1.28 billion
Net Margins: 25.10%
Return on Equity: 6.51%
Return on Assets: 2.96%

Debt:

Debt-to-Equity Ratio: 1.00%
Current Ratio: 0.50%
Quick Ratio: 0.50%

Misc:

Average Volume: 3.87 million shs.
Beta: 0.27
Short Ratio: 3.95

Frequently Asked Questions for HCP (NYSE:HCP)

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP announced a quarterly dividend on Thursday, April 27th. Investors of record on Monday, May 8th will be paid a dividend of $0.37 per share on Tuesday, May 23rd. This represents a $1.48 annualized dividend and a yield of 4.74%. The ex-dividend date of this dividend is Thursday, May 4th. View HCP's Dividend History.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) released its quarterly earnings results on Tuesday, May, 2nd. The company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.48 by $0.03. The firm earned $492.16 million during the quarter, compared to analyst estimates of $514.82 million. HCP had a net margin of 25.10% and a return on equity of 6.51%. HCP's quarterly revenue was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.69 earnings per share. View HCP's Earnings History.

What guidance has HCP issued on next quarter's earnings?

HCP updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided earnings per share (EPS) guidance of $1.89-1.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.93.

Where is HCP's stock going? Where will HCP's stock price be in 2017?

17 analysts have issued 1-year price targets for HCP's shares. Their forecasts range from $30.00 to $38.00. On average, they anticipate HCP's stock price to reach $32.58 in the next year. View Analyst Ratings for HCP.

Who are some of HCP's key competitors?

Some companies that are related to HCP include Welltower (HCN), Ventas (VTR), Omega Healthcare Investors (OHI), Senior Housing Properties Trust (SNH), Healthcare Trust Of America (HTA), Medical Properties Trust (MPW), Healthcare Realty Trust (HR), The GEO Group (GEO), Physicians Realty Trust (DOC), National Health Investors (NHI), LTC Properties (LTC), Sabra Health Care REIT (SBRA), Caretrust REIT (CTRE) and Community Healthcare Trust (CHCT).

Who owns HCP stock?

HCP's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (14.42%), BlackRock Inc. (9.82%), State Street Corp (5.82%), JPMorgan Chase & Co. (4.90%), Bank of New York Mellon Corp (2.81%) and Daiwa Securities Group Inc. (2.12%). Company insiders that own HCP stock include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Jonathan M Bergschneider, Kai Hsiao, Kendall K Young, Lauralee Martin, Peter L Rhein, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Institutional Ownership Trends for HCP.

Who sold HCP stock? Who is selling HCP stock?

HCP's stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Lasalle Investment Management Securities LLC, Daiwa Securities Group Inc., ProShare Advisors LLC, Renaissance Technologies LLC, Credit Agricole S A, Russell Investments Group Ltd. and Credit Suisse AG. Company insiders that have sold HCP stock in the last year include Darren A Kowalske, Jonathan M Bergschneider, Kendall K Young, Scott A Anderson and Thomas D Kirby. View Insider Buying and Selling for HCP.

Who bought HCP stock? Who is buying HCP stock?

HCP's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Bank of New York Mellon Corp, Vanguard Group Inc., Morgan Stanley, Capital Fund Management S.A., APG Asset Management US Inc. and Hexavest Inc.. Company insiders that have bought HCP stock in the last two years include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Kendall K Young, Lauralee Martin and Thomas D Kirby. View Insider Buying and Selling for HCP.

How do I buy HCP stock?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of HCP stock cost?

One share of HCP stock can currently be purchased for approximately $31.23.

Consensus Ratings for HCP (NYSE:HCP) (?)

Ratings Breakdown:	2 Sell Ratings, 13 Hold Ratings, 2 Buy Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$32.58 (4.33% upside)

Analysts' Ratings History for HCP (NYSE:HCP)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
5/12/2017	Jefferies Group LLC	Reiterated Rating	Hold	$32.00	High
4/24/2017	Evercore ISI	Downgrade	In-Line -> Underperform		Medium
4/21/2017	Mitsubishi UFJ Financial Group	Initiated Coverage	Hold	$32.00	Low
4/11/2017	Mizuho	Downgrade	Buy -> Neutral	$34.00 -> $32.00	Low
4/3/2017	Bank of America Corp	Upgrade	Neutral -> Buy	$33.25 -> $35.00	Low
3/20/2017	Morgan Stanley	Upgrade	Underweight -> Equal Weight	$31.00	Low
3/10/2017	Robert W. Baird	Initiated Coverage	Neutral -> Neutral	$32.00	Low
2/14/2017	BMO Capital Markets	Reiterated Rating	Hold	$30.00	N/A
2/14/2017	Barclays PLC	Boost Price Target	Equal Weight	$32.00 -> $33.00	N/A
1/25/2017	Goldman Sachs Group Inc	Upgrade	Neutral -> Buy	$29.00 -> $35.00	N/A
1/3/2017	Royal Bank of Canada	Set Price Target	Hold	$30.00	N/A
11/2/2016	Stifel Nicolaus	Upgrade	Sell -> Hold	$33.00 -> $31.00	N/A
11/1/2016	BTIG Research	Reiterated Rating	Neutral		N/A
9/18/2016	Argus	Reiterated Rating	Hold		N/A
9/4/2016	Wells Fargo & Co	Reiterated Rating	Hold		N/A
8/24/2016	Citigroup Inc	Boost Price Target	Neutral	$34.00 -> $38.00	N/A
7/26/2016	Raymond James Financial, Inc.	Initiated Coverage	Underperform		N/A
3/16/2016	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A
2/10/2016	Hilliard Lyons	Downgrade	Buy		N/A
12/17/2015	Cowen and Company	Lower Price Target	Market Perform	$40.00 -> $39.00	N/A
9/8/2015	Evercore Partners Inc.	Lower Price Target	Hold	$42.00 -> $39.00	N/A

(Data available from 5/27/2015 forward)

Earnings History for HCP (NYSE:HCP)

Earnings History by Quarter for HCP (NYSE:HCP)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2017	Q1 2017	$0.48	$0.51	$514.82 million	$492.16 million	View	Listen
2/13/2017	Q416	$0.57	$0.59	$527.10 million	$540.00 million	View	N/A
11/1/2016	Q316	$0.71	$0.72	$634.11 million	$654.30 million	View	N/A
8/9/2016	Q216	$0.70	$0.74	$631.25 million	$662.20 million	View	N/A
5/9/2016	Q116	$0.69	$0.69	$621.93 million	$640.80 million	View	N/A
2/9/2016	Q415	$0.78	$0.80	$658.05 million	$668.00 million	View	N/A
11/3/2015	Q315	$0.77	$0.79	$599.42 million	$657.95 million	View	N/A
8/4/2015	Q215	$0.76	$0.79	$582.84 million	$607.50 million	View	Listen
5/5/2015	Q115	$0.78	$0.79	$585.51 million	$610.80 million	View	Listen
2/10/2015	Q414	$0.77	$0.79	$584.82 million	$603.53 million	View	Listen
11/4/2014	Q314	$0.76	$0.75	$534.60 million	$596.60 million	View	Listen
8/5/2014	Q214	$0.75	$0.75	$523.50 million	$536.12 million	View	Listen
5/6/2014	Q114	$0.74	$0.75	$518.87 million	$530.00 million	View	Listen
2/11/2014	Q413	$0.74	$0.76	$510.39 million	$530.30 million	View	Listen
10/29/2013	Q313	$0.76	$0.79	$520.90 million	$543.96 million	View	Listen
7/30/2013	Q213	$0.74	$0.72	$518.53 million	$516.30 million	View	Listen
4/30/2013	Q113	$0.72	$0.74		$516.30 million	View	Listen
2/12/2013	Q412	$0.71	$0.71	$482.51 million	$508.49 million	View	Listen
10/30/2012	Q312	$0.69	$0.69	$466.58 million		View	N/A
7/31/2012		$0.68	$0.69			View	N/A
5/1/2012		$0.66	$0.67			View	N/A
2/14/2012		$0.66	$0.67			View	N/A
10/31/2011		$0.66	$0.67			View	N/A
8/2/2011		$0.76	$0.77			View	N/A
5/3/2011		$0.46	$0.56			View	N/A
2/15/2011		$0.59	$0.64			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for HCP (NYSE:HCP)

2017 EPS Consensus Estimate: $2.37

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	2	$0.48	$0.71	$0.60
Q2 2017	2	$0.47	$0.73	$0.60
Q3 2017	2	$0.48	$0.68	$0.58
Q4 2017	2	$0.49	$0.69	$0.59

(Data provided by Zacks Investment Research)

Current Dividend Information for HCP (NYSE:HCP)

Most Recent Dividend:	5/23/2017
Annual Dividend:	$1.48
Dividend Yield:	4.74%
Dividend Growth:	-0.10% (3 Year Average)
Payout Ratio:	111.28% (Trailing 12 Months of Earnings) 112.98% (Based on This Year's Estimates) 174.12% (Based on Next Year's Estimates)

Dividend Payments by Quarter for HCP (NYSE:HCP)

Dividend History by Quarter for HCP (NYSE:HCP)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/27/2017	quarterly	$0.37	4.72%	5/4/2017	5/8/2017	5/23/2017
2/2/2017	quarterly	$0.37	4.81%	2/13/2017	2/15/2017	3/2/2017
11/1/2016	quarterly	$0.37		11/8/2016	11/10/2016	11/25/2016
7/28/2016	quarterly	$0.58	5.86%	8/4/2016	8/8/2016	8/23/2016
4/27/2016	quarterly	$0.58	6.78%	5/5/2016	5/9/2016	5/24/2016
1/28/2016	quarterly	$0.58	6.29%	2/4/2016	2/8/2016	2/23/2016
10/29/2015	quarterly	$0.57	6.08%	11/5/2015	11/9/2015	11/24/2015
7/30/2015	quarterly	$0.57	5.85%	8/6/2015	8/10/2015	8/25/2015
4/30/2015	quarterly	$0.57	5.55%	5/7/2015	5/11/2015	5/26/2015
1/29/2015	quarterly	$0.57	4.78%	2/5/2015	2/9/2015	2/24/2015
10/30/2014	quarterly	$0.55	4.96%	11/6/2014	11/10/2014	11/25/2014
7/31/2014	quarterly	$0.55	5.22%	8/7/2014	8/11/2014	8/26/2014
5/6/2014	quarterly	$0.55			5/27/2014	5/6/2014
5/1/2014	quarterly	$0.55	5.18%	5/8/2014	5/12/2014	5/27/2014
1/30/2014		$0.53		2/6/2014	2/10/2014	2/25/2014
1/30/2014	quarterly	$0.55	5.57%	2/6/2014	2/10/2014	2/25/2014
10/24/2013	quarterly	$0.53	4.88%	10/31/2013	11/4/2013	11/19/2013
7/25/2013	quarterly	$0.53	4.63%	8/1/2013	8/5/2013	8/20/2013
4/25/2013	quarterly	$0.53	3.98%	5/2/2013	5/6/2013	5/21/2013
1/25/2013	quarterly	$0.53	4.48%	1/31/2013	2/4/2013	2/19/2013

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for HCP (NYSE:HCP)

Insider Ownership Percentage: 0.22%
Institutional Ownership Percentage: 92.37%

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Insider Trades by Quarter for HCP (NYSE:HCP)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/16/2017	Scott A Anderson	CAO	Sell	10,000	$29.94	$299,400.00
9/7/2016	Thomas D. Kirby	Insider	Sell	3,000	$40.24	$120,720.00
8/31/2016	Darren A Kowalske	Insider	Sell	2,250	$39.20	$88,200.00
8/24/2016	Kendall K Young	Insider	Sell	9,000	$39.46	$355,140.00
8/23/2016	Jonathan M Bergschneider	EVP	Sell	7,651	$39.78	$304,356.78
5/9/2016	Kai Hsiao	EVP	Sell	266	$36.04	$9,586.64
2/12/2016	Thomas D Kirby	EVP	Buy	500	$26.10	$13,050.00
2/11/2016	Darren A Kowalske	EVP	Buy	3,822	$26.12	$99,830.64
2/11/2016	Lauralee Martin	CEO	Buy	25,000	$25.39	$634,750.00
2/10/2016	James Justin Hutchens	EVP	Buy	10,000	$27.47	$274,700.00
12/8/2015	Peter L Rhein	Director	Sell	5,600	$36.43	$204,008.00
11/11/2015	James Justin Hutchens	EVP	Buy	3,000	$33.09	$99,270.00
11/11/2015	James P Hoffmann	Director	Buy	10,000	$33.00	$330,000.00
11/6/2015	Kendall K Young	EVP	Buy	2,900	$33.95	$98,455.00
6/12/2015	Thomas Klaritch	EVP	Sell	32,875	$38.20	$1,255,825.00
8/29/2014	Thomas D Kirby	EVP	Sell	672	$43.25	$29,064.00
8/27/2014	Thomas Klaritch	EVP	Sell	2,925	$42.74	$125,014.50
6/16/2014	Thomas Klaritch	EVP	Sell	40,000	$41.29	$1,651,600.00
6/2/2014	Kendall K Young	EVP	Sell	5,114	$42.12	$215,401.68
6/2/2014	Peter L Rhein	Director	Sell	5,000	$41.89	$209,450.00
5/14/2014	Susan Tate	EVP	Sell	23,311	$42.25	$984,889.75
5/15/2013	Scott A Anderson	CAO	Sell	3,826	$54.07	$206,871.82
11/26/2012	Thomas D Kirby	EVP	Sell	1,000	$46.05	$46,050.00

(Data available from 1/1/2013 forward)

Headline Trends for HCP (NYSE:HCP) Latest Headlines for HCP (NYSE:HCP)

Source:

Date	Headline
	LTC Properties: Monthly Dividend Healthcare REIT seekingalpha.com - May 19 at 10:09 AM
	HCP Appoints Scott Brinker as Chief Investment Officer - PR Newswire (press release) www.prnewswire.com - May 16 at 5:32 PM
	HCP, Inc. (HCP) Appoints Scott Brinker as CIO www.streetinsider.com - May 15 at 11:09 AM
	HCP, Inc. breached its 50 day moving average in a Bullish Manner : HCP-US : May 15, 2017 finance.yahoo.com - May 15 at 11:09 AM
	HCP Appoints Scott Brinker as Chief Investment Officer finance.yahoo.com - May 15 at 11:09 AM
	FY2017 Earnings Estimate for HCP, Inc. Issued By Jefferies Group (HCP) www.americanbankingnews.com - May 12 at 12:52 PM
	HCP's (HCP) "Hold" Rating Reaffirmed at Jefferies Group LLC www.americanbankingnews.com - May 12 at 7:46 AM
	HCP, Inc. (HCP) to Post Q2 2017 Earnings of $0.47 Per Share, Jefferies Group Forecasts www.americanbankingnews.com - May 11 at 8:34 AM
	Should You Retain HCP Inc. (HCP) Stock in Your Portfolio? finance.yahoo.com - May 9 at 12:40 PM
	HCP (HCP) Getting Somewhat Favorable News Coverage, Study Shows www.americanbankingnews.com - May 6 at 12:33 AM
	Brokerages Set HCP, Inc. (HCP) Price Target at $32.48 www.americanbankingnews.com - May 5 at 10:58 PM
	HCP (HCP) Q1 2017 Results - Earnings Call Transcript seekingalpha.com - May 4 at 5:48 PM
	HCP, Inc. : HCP-US: Dividend Analysis : May 08th, 2017 (record date) : By the numbers : May 4, 2017 finance.yahoo.com - May 4 at 5:48 PM
	HCP Inc. (HCP) Q1 FFO Beats Estimates, Deleveraging on Track - Nasdaq www.nasdaq.com - May 4 at 1:41 AM
	HCP Inc. (HCP) Q1 FFO Beats Estimates, Revenues Lag - Nasdaq www.nasdaq.com - May 3 at 3:41 PM
	HCP, Inc. (HCP) Ex-Dividend Date Scheduled for May 04, 2017 - Nasdaq www.nasdaq.com - May 3 at 3:41 PM
	Edited Transcript of HCP earnings conference call or presentation 2-May-17 4:00pm GMT finance.yahoo.com - May 3 at 3:41 PM
	HCP, Inc. breached its 50 day moving average in a Bearish Manner : HCP-US : May 3, 2017 finance.yahoo.com - May 3 at 3:41 PM
	HCP, Inc. (HCP) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - May 2 at 8:50 PM
	HCP, Inc. (HCP) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS www.americanbankingnews.com - May 2 at 6:08 PM
	HCP Earnings: Moving in the Right Direction www.fool.com - May 2 at 5:22 PM
	HCP Inc. (HCP) Q1 FFO Beats Estimates, Deleveraging on Track finance.yahoo.com - May 2 at 4:08 PM
	HCP, Inc. Reveals 7% Advance In Q1 Earnings www.nasdaq.com - May 2 at 10:04 AM
	HCP Announces Results for the Quarter Ended March 31, 2017 finance.yahoo.com - May 2 at 10:04 AM
	HCP reports 1Q results finance.yahoo.com - May 2 at 10:04 AM
	HCP Inc. (HCP) Q1 FFO Beats Estimates, Revenues Lag finance.yahoo.com - May 2 at 10:04 AM
	HCP, Inc. (HCP) Releases FY17 Earnings Guidance www.americanbankingnews.com - May 2 at 9:56 AM
	Should You Sell HCP, Inc. (HCP) Before Earnings? - Yahoo Finance finance.yahoo.com - May 1 at 1:36 PM
	Should You Sell HCP, Inc. (HCP) Before Earnings? finance.yahoo.com - May 1 at 1:36 PM
	Analysts Anticipate HCP, Inc. (HCP) Will Announce Quarterly Sales of $522.59 Million www.americanbankingnews.com - April 30 at 9:14 AM
	HCP (HCP) Receives News Sentiment Score of 0.15 www.americanbankingnews.com - April 30 at 12:45 AM
	REIT Stocks on Investors' Radar -- HCP Inc., Medical Properties ... - PR Newswire (press release) www.prnewswire.com - April 28 at 6:36 PM
	HCP Declares Quarterly Cash Dividend on Common Stock - PR Newswire (press release) www.prnewswire.com - April 28 at 6:36 PM
	Better Buy: HCP, Inc. vs. Ventas - Motley Fool www.fool.com - April 28 at 6:36 PM
	Better Buy: HCP, Inc. vs. Ventas www.fool.com - April 28 at 3:55 PM
	$0.48 Earnings Per Share Expected for HCP, Inc. (HCP) This Quarter www.americanbankingnews.com - April 28 at 1:48 PM
	HCP, Inc. (HCP) Declares Quarterly Dividend of $0.37 www.americanbankingnews.com - April 27 at 10:12 PM
	HCP Declares Quarterly Cash Dividend on Common Stock finance.yahoo.com - April 27 at 8:35 PM
	American Tower (AMT) Beats Q1 Earnings, Revenue Estimates www.zacks.com - April 27 at 3:34 PM
	Decade in the making, massive biotech project set to break ground in South S.F. www.bizjournals.com - April 27 at 3:34 PM
	Somewhat Favorable Press Coverage Very Likely to Impact HCP (HCP) Stock Price www.americanbankingnews.com - April 26 at 8:34 PM
	Evercore ISI Lowers HCP, Inc. (HCP) to Underperform www.americanbankingnews.com - April 24 at 11:30 AM
	HCP (HCP) Receiving Somewhat Negative Press Coverage, AlphaOne Reports www.americanbankingnews.com - April 23 at 11:01 AM
	HCP, Inc. (HCP) Coverage Initiated at Mitsubishi UFJ Financial Group www.americanbankingnews.com - April 21 at 5:40 PM
	Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharmaceutical ... www.nasdaq.com - April 21 at 3:22 PM
	Somewhat Favorable News Coverage Very Likely to Affect HCP (HCP) Stock Price www.americanbankingnews.com - April 20 at 9:47 PM
	What's in Store for UDR Inc. (UDR) this Earnings Season? www.nasdaq.com - April 20 at 4:06 PM
	Jefferies Group Weighs in on HCP, Inc.'s Q1 2017 Earnings (HCP) www.americanbankingnews.com - April 18 at 11:01 AM
	HCP (HCP) Earning Somewhat Positive Press Coverage, Analysis Shows www.americanbankingnews.com - April 16 at 2:35 PM
	Robbins Arroyo LLP: HCP, Inc. (HCP) Misled Shareholders According to a Recently Filed Shareholder Derivative Lawsuit - Business Wire (press release) www.businesswire.com - April 16 at 10:26 AM